Why the study?
AI-enhanced 12-lead ECG can detect structural heart diseases, but its role in community-based screening is limited.
Does a noise-resilient single-lead AI-ECG algorithm detect and predict structural heart diseases using wearable/portable devices?
Does a noise-resilient single-lead AI-ECG algorithm detect and predict structural heart diseases using wearable/portable devices?
A novel noise-resilient single-lead AI-ECG algorithm can detect and predict structural heart diseases, potentially enabling community-based screening using wearable devices.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“By enabling low-cost, scalable SHD screening beyond traditional care pathways, AI-ECG solutions like ADAPT-HEART can reach underserved populations and identify patients in the early, asymptomatic stages of disease—where timely interventions are most impactful. Their call to action is clear: as intelligent tools increasingly meet clinical-grade validation, we must focus on integrating them thoughtfully into real-world practice to maximise equity and efficacy in cardiovascular care.”
“The quality of the 'single-lead' ECG extracted from lead I of the 12-lead ECGs in this study may vary significantly from the noisy ECG waveform obtained from peripheral devices, which are often affected by muscle artefacts and impedance from dry skin contact.”
May support wearable AI-ECG screening for structural heart disease; leaves open prospective validation before clinical adoption.
Aims: Artificial intelligence (AI)-enhanced 12-lead electrocardiogram (ECG) can detect a range of structural heart diseases (SHDs); however, it has a limited role in community-based screening. We developed and externally validated a noise-resilient single-lead AI-ECG algorithm that can detect SHDs and predict the risk of their development using wearable/portable devices. Methods and Conclusion: We propose a novel model that detects and predicts a range of SHDs from noisy single-lead ECGs obtainable on portable/wearable devices, providing a scalable strategy for community-based screening and risk stratification for SHD.
No takes yet. Share an insight, caveat, or question.
Aminorroaya et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: